Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Eichmann

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Diabetes|May 20, 2022
T-Cell Autoreactivity in Type 2 Diabetes: Benign or Pathogenic, Smoke or Fire?Angus G Jones, Martin Eichmann
Journal of Autoimmunity|August 15, 2017
New insights into non-conventional epitopes as T cell targets: The missing link for breaking immune tolerance in autoimmune disease?James Harbige, Martin Eichmann, Mark Peakman
Current Opinion in Endocrinology, Diabetes, and Obesity|July 4, 2020
Assessing effector T cells in type 1 diabetesSefina Arif, Irma Pujol-Autonell, Martin Eichmann
Journal of Autoimmunity|September 8, 2015
T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive reviewIria Gomez-Tourino, Sefina Arif, Martin Eichmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2015
Heterogeneity in the Locomotory Behavior of Human Monocyte Subsets over Human Vascular Endothelium In VitroJoanna L Collison, Leo M Carlin, Martin Eichmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2020
Costimulation Blockade Disrupts CD4<sup>+</sup> T Cell Memory Pathways and Uncouples Their Link to Decline in β-Cell Function in Type 1 DiabetesMartin Eichmann, Roman Baptista, Richard J Ellis, et al.
Diabetologia|December 21, 2025
Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetesRebecca E Dewhurst-Trigg, Jocelyn Atkins, Noel G Morgan, et al.
Diabetes|September 1, 2012
Human β-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon T-cell receptor avidityRobin R Knight, Deborah Kronenberg, Min Zhao, et al.
Diabetes|January 19, 2018
Molecular Pathways for Immune Recognition of Preproinsulin Signal Peptide in Type 1 DiabetesDeborah Kronenberg-Versteeg, Martin Eichmann, Mark A Russell, et al.
Diabetes|April 24, 2012
Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cellsDeborah Kronenberg, Robin R Knight, Megan Estorninho, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Diabetes|May 20, 2022
T-Cell Autoreactivity in Type 2 Diabetes: Benign or Pathogenic, Smoke or Fire?Angus G Jones, Martin Eichmann
Journal of Autoimmunity|August 15, 2017
New insights into non-conventional epitopes as T cell targets: The missing link for breaking immune tolerance in autoimmune disease?James Harbige, Martin Eichmann, Mark Peakman
Current Opinion in Endocrinology, Diabetes, and Obesity|July 4, 2020
Assessing effector T cells in type 1 diabetesSefina Arif, Irma Pujol-Autonell, Martin Eichmann
Journal of Autoimmunity|September 8, 2015
T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive reviewIria Gomez-Tourino, Sefina Arif, Martin Eichmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2015
Heterogeneity in the Locomotory Behavior of Human Monocyte Subsets over Human Vascular Endothelium In VitroJoanna L Collison, Leo M Carlin, Martin Eichmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2020
Costimulation Blockade Disrupts CD4<sup>+</sup> T Cell Memory Pathways and Uncouples Their Link to Decline in β-Cell Function in Type 1 DiabetesMartin Eichmann, Roman Baptista, Richard J Ellis, et al.
Diabetologia|December 21, 2025
Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetesRebecca E Dewhurst-Trigg, Jocelyn Atkins, Noel G Morgan, et al.
Diabetes|September 1, 2012
Human β-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon T-cell receptor avidityRobin R Knight, Deborah Kronenberg, Min Zhao, et al.
Diabetes|January 19, 2018
Molecular Pathways for Immune Recognition of Preproinsulin Signal Peptide in Type 1 DiabetesDeborah Kronenberg-Versteeg, Martin Eichmann, Mark A Russell, et al.
Diabetes|April 24, 2012
Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cellsDeborah Kronenberg, Robin R Knight, Megan Estorninho, et al.
Pageof 2